US Pre-Market SEC Filings Roundup — February 24, 2026

25-02-2026

25-02-2026

ANAVEX LIFE SCIENCES CORP. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

25-02-2026

Biomea Fusion, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core events, financial metrics, transactions, positive or negative performance indicators, or quantitative data are explicitly stated in the filing summary. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance with attached exhibits.

25-02-2026

LivaNova PLC filed a Form 8-K on February 25, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, margins, or period-over-period metrics are detailed in the provided filing information. No positive or negative performance indicators, guidance, or balance sheet impacts are mentioned.

25-02-2026

VisionWave Holdings, Inc. filed an 8-K on February 25, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, typically following an annual or special shareholder meeting. No specific proposals, vote outcomes, numerical results (e.g., for/against/abstain/broker non-votes), or other details are disclosed in the provided filing information. This is a routine informational disclosure with no financial or operational metrics mentioned.

25-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events, which discloses a material event not covered by other specific items. The filing also includes Item 9.01 Financial Statements and Exhibits, indicating attachments such as financial data or agreements. No specific details on the event, transaction values, financial metrics, or performance comparisons are disclosed in the provided filing summary.

25-02-2026

Taboola.com Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006649), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are available.

25-02-2026

Clear Secure, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results without detailed quantitative data.

25-02-2026

Dole plc filed a Form 8-K on 2026-02-25 (AccNo: 0001857475-26-000014, Size: 1 MB) disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary filing typical for earnings releases. No specific financial metrics, period-over-period comparisons, guidance, or performance details (positive, negative, or flat) are disclosed in the provided filing information.

25-02-2026

Battalion Oil Corp filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 includes financial statements and exhibits, likely pro forma financials related to the transaction. No specific details on deal structure, parties, valuation, synergies, or quantitative metrics are disclosed in the provided filing information.

25-02-2026

WESCO INTERNATIONAL INC filed an 8-K on February 25, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the nature of the exhibits are disclosed. No financial metrics, transactions, or performance data are provided.

25-02-2026

Archrock, Inc. filed an 8-K on 2026-02-25 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results with no specific revenue, earnings, guidance, or other metrics provided in the filing information. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are disclosed.

25-02-2026

The company filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019327) under Item 5.02 disclosing an officer change event dated February 25, 2026. No specific details regarding the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment or resignation), reason, or timing are disclosed. This filing provides no quantitative data, financial metrics, or further context on governance implications.

25-02-2026

Verses AI Inc. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.

25-02-2026

Ashford Hospitality Trust Inc filed an 8-K on 2026-02-25 under Item 5.02 disclosing potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. No specific names, positions affected, reasons for changes, timing, or other details are disclosed. This filing provides informational disclosure on leadership and governance matters without quantified financial impacts or directional bias.

25-02-2026

Luminar Technologies, Inc./DE filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are explicitly stated in the provided filing information. The disclosure appears informational with attached exhibits, but core content is NOT_DISCLOSED.

25-02-2026

Avista Corp filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item filing for financial results announcement. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing details.

• ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
• ·Accession Number: 0001193125-26-067873
• ·Filing size: 8 MB

25-02-2026

LifeStance Health Group, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including key position, appointment or resignation, reasons, or timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

25-02-2026

TALOS ENERGY INC. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-067747, Size: 1 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other quantitative metrics. No positive or negative performance indicators, guidance, or comparisons are detailed in the filing description.

25-02-2026

Arcosa, Inc. filed a Form 8-K on February 25, 2026, disclosing entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, financial metrics, transaction values, or performance comparisons are provided in the filing summary. This multi-item filing indicates potentially significant developments, but lacks quantitative data or directional indicators.

25-02-2026

News Corp filed a Form 8-K on February 25, 2026 (AccNo: 0001564708-26-000041), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing summary. This appears to be a multi-item, voluntary disclosure under Item 8.01 with required exhibit listing.

25-02-2026

25-02-2026

Hippo Holdings Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified details.

25-02-2026

Postal Realty Trust, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011279, Size: 377 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This multi-item filing is a standard voluntary disclosure for earnings releases. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing details.

25-02-2026

Hyliion Holdings Corp. filed an 8-K on 2026-02-25 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are detailed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.

25-02-2026

FLUSHING FINANCIAL CORP filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided in the filing summary. No positive or negative metrics, changes, or impacts are mentioned.

25-02-2026

Kosmos Energy Ltd. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

25-02-2026

Blackstone Secured Lending Fund filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or quantitative financial metrics are disclosed in the provided filing details. This is an informational earnings-related disclosure with no directional financial data available.

• ·AccNo: 0001213900-26-020083
• ·Filing size: 30 MB
• ·Sector: not specified
• ·Critical missing information: All financial metrics (revenue, earnings, margins, YoY/QoQ changes), guidance, balance sheet details, scheduled events (earnings calls), insider activity, and specific results of operations; data completeness LOW (<50%)

25-02-2026

Shoe Carnival Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed in the provided information. No quantitative data or directional indicators provided.

25-02-2026

OZOP Energy Solutions, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-007952, Size: 192 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, quantitative data, or other details are explicitly stated in the provided filing information. Sector is not specified.

25-02-2026

Circle Internet Group, Inc. filed a Form 8-K on 2026-02-25 reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No period-over-period comparisons, balance sheet effects, or outlook revisions are provided in the filing summary.

25-02-2026

UnitedHealth Group Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, or other metrics are mentioned.

• ·AccNo: 0000731766-26-000046
• ·File size: 189 KB
• ·Event date: 2026-02-25
• ·Sector: NOT_DISCLOSED

25-02-2026

Owens Corning filed an 8-K on February 25, 2026 (AccNo: 0001370946-26-000066), reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

25-02-2026

UNITED THERAPEUTICS Corp filed a Form 8-K on February 25, 2026 (AccNo: 0001082554-26-000007, Size: 536 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard earnings-related disclosure for a US biotech/pharma company, but no specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

• ·File size: 536 KB

25-02-2026

Broadstone Net Lease, Inc. filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or quantitative data are disclosed in the filing summary provided. This appears to be a voluntary disclosure of material non-public information with attached exhibits, but details are NOT_DISCLOSED.

25-02-2026

AMC Entertainment Holdings, Inc. filed an 8-K on February 25, 2026, under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative data extracted.

25-02-2026

Bloomin' Brands, Inc. filed a Form 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

25-02-2026

Recursion Pharmaceuticals, Inc. filed an 8-K on February 25, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other metrics. No period-over-period comparisons, guidance, or directional performance indicators (positive, negative, or flat) are mentioned.

25-02-2026

Alexander & Baldwin, Inc. filed a Form 8-K on February 25, 2026, specifically under Item 8.01 Other Events. No details on the core event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This appears to be a single-item filing with no quantitative data or period-over-period comparisons mentioned.

25-02-2026

Aspen Aerogels Inc filed an 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.

25-02-2026

Hut 8 Corp. filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were mentioned in the filing description. This is an informational filing with all quantitative financial metrics NOT_DISCLOSED.

25-02-2026

Starwood Property Trust, Inc. filed an 8-K on February 25, 2026, under Item 2.02 announcing results of operations and financial condition. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative metrics available.

25-02-2026

O-I Glass, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.

25-02-2026

BLACKBOXSTOCKS INC. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with a change in control of the registrant (Item 5.01), unregistered sales of equity securities (Item 3.02), and material modifications to rights of security holders (Item 3.03). Governance changes include departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and amendments to the code of ethics (Item 5.05). Additional items cover Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01); no quantitative metrics, deal terms, or parties were disclosed.

25-02-2026

Acadia Healthcare Company, Inc. filed an 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.

25-02-2026

Lineage, Inc. filed an 8-K on February 25, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results on a voluntary basis. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data are provided in the filing details.

25-02-2026

Alkermes plc filed an 8-K on February 25, 2026, under Item 2.02 reporting results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified details available.

25-02-2026

BKV Corp filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings announcements, but no specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. Critical financial details such as period-over-period changes, balance sheet impacts, or outlook revisions are NOT_DISCLOSED.

• ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
• ·AccNo: 0001628280-26-011383, File size: 895 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

Amarin Corp PLC/UK filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-068511, size 759 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector details are not specified.

25-02-2026

Hayward Holdings, Inc. filed an 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

25-02-2026

Astec Industries Inc filed a Form 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, period-over-period changes, or guidance metrics were detailed in the provided filing information. No positive or negative performance indicators, balance sheet impacts, or strategic updates were explicitly stated.

25-02-2026

Ionis Pharmaceuticals Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are explicitly stated in the provided filing details. This is a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

25-02-2026

Photronics Inc filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006717), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no directional performance indicators available.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Size: 6 MB
• ·Sector: not specified

25-02-2026

Steven Madden, Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-007955, Size: 536 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data are disclosed in the provided filing description. This appears to be a standard multi-item earnings-related disclosure with sector NOT_DISCLOSED.

25-02-2026

US Energy Corp filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. The filing size is 5 MB with Accession Number 0001437749-26-005430.

25-02-2026

Driven Brands Holdings Inc. filed an 8-K on February 25, 2026 (AccNo: 0001804745-26-000016, Size: 142 KB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific financial metrics, transactions, events, or quantitative data disclosed in the provided summary. No positive or negative performance indicators are mentioned.

25-02-2026

Dine Brands Global, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-068524), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific revenue, earnings, margins, comparisons, guidance, or other numerical metrics are disclosed in the provided information.

25-02-2026

Geron Corp filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were mentioned in the filing summary. This is a standard multi-item earnings-related disclosure with no directional financial performance data provided.

25-02-2026

Ironwood Pharmaceuticals Inc filed an 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard financial results announcement with no period-over-period comparisons or directional indicators available.

25-02-2026

Angel Oak Mortgage REIT, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are detailed in the provided information. No positive or negative performance indicators, guidance, or comparisons were mentioned.

25-02-2026

Medline Inc. filed an 8-K on February 25, 2026 (AccNo: 0002046386-26-000007, Size: 529 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with attached exhibits.

25-02-2026

Charles River Laboratories International, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011395, Size: 160 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

25-02-2026

CS Disco, Inc. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the filing description. This is a standard voluntary earnings disclosure without detailed quantitative metrics provided.

• ·Accession Number: 0001625641-26-000043
• ·File Size: 474 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

25-02-2026

DiamondRock Hospitality Co filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the affected officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

25-02-2026

HNI CORP filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics were mentioned. No positive, negative, or flat performance indicators were detailed in the provided filing information.

25-02-2026

Crane NXT, Co. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure, which typically involves voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, indicating attachments were provided. No specific details, events, transactions, financial metrics, or numerical data are disclosed in the provided filing summary. This is a multi-item filing with no information on timing relative to events or market expectations.

25-02-2026

MGP Ingredients Inc filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This multi-item filing reports financial results but no specific revenue, earnings, margins, or other quantitative metrics were detailed in the provided information. No positive or negative performance indicators, comparisons, or guidance changes were mentioned.

25-02-2026

Immunocore Holdings plc filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified metrics available.

• ·Sector not specified in filing.
• ·No details on market expectations, guidance changes, or balance sheet effects provided.

25-02-2026

Corbus Pharmaceuticals Holdings, Inc. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure, which is a voluntary release of material non-public information to ensure broad dissemination, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents such as a press release or presentation (file size 22 MB). No specific transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the filing summary. This is a multi-item, primarily voluntary disclosure with no details on timing relative to the 4-business-day requirement.

25-02-2026

APi Group Corp filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011397), furnishing Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

25-02-2026

GCT Semiconductor Holding, Inc. filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

25-02-2026

Tempest Therapeutics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-068614), reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item, likely voluntary disclosure filing with no specific core events, transactions, financial metrics, or quantitative data explicitly stated in the provided filing summary. No positive or negative performance metrics, guidance changes, or scheduled events are disclosed.

25-02-2026

Centuri Holdings, Inc. filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

25-02-2026

Atlanta Braves Holdings, Inc. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without detailed financial data available.

25-02-2026

Icahn Enterprises L.P. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the filing details provided. This appears to be a standard multi-item earnings-related disclosure without quantified metrics.

25-02-2026

Incannex Healthcare Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001213900-26-020127), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the nature of the modifications, amendments, events, or exhibits. No quantitative metrics, financial impacts, positive or negative changes, or period-over-period comparisons are disclosed.

25-02-2026

Trinity Capital Inc. filed a Form 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific quantitative metrics, period-over-period comparisons, guidance, or other performance data explicitly stated in the provided filing information. No positive or negative financial impacts are detailed.

25-02-2026

Southwest Gas Holdings, Inc. filed a Form 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure without detailed performance data.

• ·Accession Number: 0001692115-26-000060
• ·File Size: 479 KB

25-02-2026

NEWMARK GROUP, INC. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period metrics are disclosed in the provided filing information. No positive or negative financial changes can be assessed due to lack of extracted data.

25-02-2026

Empire Petroleum Corp filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the filing summary provided. No quantitative metrics, positive or negative changes, or directional performance indicators are mentioned.

25-02-2026

Pinnacle West Capital Corp filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or period-over-period metrics are provided in the filing summary. The disclosure is informational without quantified financial impacts.

25-02-2026

Wells Fargo & Company filed an 8-K on February 25, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are provided in the filing summary. This appears to be a multi-item informational filing with no quantified financial metrics, positive or negative developments explicitly stated.

25-02-2026

Tri Pointe Homes, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001561680-26-000004), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified financial metrics available.

25-02-2026

Graham Holdings Co filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons were mentioned. No positive or negative metrics were detailed.

25-02-2026

Cardiff Oncology, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068668, Size: 17 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving voluntary disclosure of potentially material non-public information with attached exhibits. No financial metrics, transactions, events, or quantitative data are specified in the filing metadata.

25-02-2026

Allurion Technologies, Inc. filed a Form 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 3.03 material modifications to rights of security holders, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, or financial impacts are disclosed. No positive or negative metrics, period-over-period comparisons, or strategic context are provided in the available information.

• ·Multi-item 8-K filing covering agreement entry, equity sales, and rights changes
• ·AccNo: 0001193125-26-068667
• ·File size: 556 KB

25-02-2026

Signing Day Sports, Inc. filed a Form 8-K on 2026-02-25 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of material non-public information with attached exhibits, but no specific details, financial metrics, transactions, or quantitative data are provided in the filing summary. No positive or negative performance indicators are mentioned.

25-02-2026

Intuitive Machines, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068729), reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, financial metrics, or performance comparisons disclosed in the provided information. No positive or negative metrics are mentioned.

25-02-2026

UWM Holdings Corp filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, or other metrics are disclosed in the provided filing information.

25-02-2026

Lowe's Companies Inc filed an 8-K on February 25, 2026 (AccNo: 0000060667-26-000020), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This appears to be a multi-item, mandatory disclosure for earnings-related updates, with exhibits likely including press releases or statements.

25-02-2026

Pitney Bowes Inc. /DE/ filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068707, size: 174 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. No positive or negative performance indicators, scheduled events, or strategic details are mentioned.

25-02-2026

Reliance Global Group, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement terms, equity sales volume, or disclosures are provided. This is a multi-item mandatory filing with no quantitative impacts or period-over-period comparisons disclosed.